Parkinson's Disease: Biomarkers

Parkinson’s disease is a neurodegenerative disease characterized by involuntary movement, decreased movement, rigidity, and abnormal walking and posture. Targeting markers in the earliest stages of the disease may mitigate its progression. This feed focuses on biomarkers for Parkinson’s disease.

December 7, 2021

Neuroimaging cerebrovascular biomarkers in Parkinson's disease.

The Neuroradiology Journal
Mariana AlvesSofia Reimão
December 7, 2021

Multi-task learning based structured sparse canonical correlation analysis for brain imaging genetics.

Medical Image Analysis
Mansu KimLi Shen
December 6, 2021
Open Access

Parkinson's Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs.

Frontiers in Immunology
Kasra Honarmand TamizkarSoudeh Ghafouri-Fard
December 6, 2021
Open Access

Neurophysiological Predictors of Response to Medication in Parkinson's Disease.

Frontiers in Neurology
Saša R FilipovićMiloš R Ljubisavljević
December 6, 2021
Open Access

Segmental Alterations of the Corpus Callosum in Progressive Supranuclear Palsy: A Multiparametric Magnetic Resonance Imaging Study.

Frontiers in Aging Neuroscience
Lavinia A BârlescuJan Kassubek
December 6, 2021
Review
Open Access

It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer's and Lewy Body Disease Spectra.

Frontiers in Systems Neuroscience
Noritaka Wakasugi, Takashi Hanakawa
December 6, 2021

Biomarkers of Cerebral Glucose Metabolism and Neurodegeneration in Parkinson's Disease: A Cerebrospinal Fluid-Based Study.

Journal of Parkinson's Disease
Claudio LiguoriMariangela Pierantozzi
December 6, 2021

Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study.

Parkinsonism & Related Disorders
Sid E O'BryantJames Hall
December 5, 2021
Preprint
Open Access

Asymptomatic carriers of the p.A53T SNCA mutation: data from the PPMI study

MedRxiv : the Preprint Server for Health Sciences
A. M. SimitsiL. Stefanis
December 5, 2021
Preprint
Open Access

Serum uric acid and total bilirubin as putative biomarkers of resistance in Prodromal Parkinson's disease: Longitudinal data from the PPMI study.

MedRxiv : the Preprint Server for Health Sciences
Christos KorosM. Stamelou
December 4, 2021
Review

Lewy Body Dementias: Controversies and Drug Development.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Shannon Y ChiuMelissa J Armstrong
December 4, 2021
Review

Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future.

Journal of Pharmaceutical and Biomedical Analysis
Münteha Nur Sonuç Karaboğa, Mustafa Kemal Sezgintürk
December 4, 2021

Brain atrophy progression in Parkinson's disease is shaped by connectivity and local vulnerability.

Brain Communications
Christina TremblayAlain Dagher
December 4, 2021

Mapping the serum proteome to neurological diseases using whole genome sequencing.

Nature Communications
Grace PngEleftheria Zeggini
December 4, 2021
Open Access

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods.

Frontiers in Aging Neuroscience
Kuo-Hsuan ChangChiung-Mei Chen
December 4, 2021
Open Access

Controlling Clinical States Governed by Different Temporal Dynamics With Closed-Loop Deep Brain Stimulation: A Principled Framework.

Frontiers in Neuroscience
Gerd Tinkhauser, Eduardo Martin Moraud

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-biomarkers/28ca42d2-e7b5-4c4f-9932-3384c44e101f